]>
IRCT20201209049655N1 IRCT 2021-02-22 Arak University of Medical Sciences The effect of low-level laser therapy on spontaneous nerve pain The Effect Of LLLT(low level laser therapy) On Idiopathic Trigeminal Neuralgia Pain 2021-02-28 anticipated 24 Complete https://irct.ir/trial/53748 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Samples are randomly divided into intervention and control groups. For this purpose, AABB, ABAB, BBAA, BABA, ABBA and BAAB quadruple blocks are used to balance the allocation to each group. It is also a method of selecting a random block using a table of random numbers, Blinding description: This study is a double-blind study. Due to the fact that laser treatment is performed for one group and silent laser is applied for the other group, patients are unaware of which group they are in. The researcher who meets the VAS criteria for the patient is also unaware of what group he or she belongs to. 3 Neuralgia. Intervention 1: Intervention group: Treatment will start with 100 mg of carbamazepine and add 100 mg to the dose once every three days (depending on the patient's pain intensity). This process continues until the pain relief (increase to the maximum allowable dose). laser therapy is performed by rays with a wavelength of 940 nm with a density energy of 10 joules per square centimeter continuously (Biolase Technology, 940 diode, CA, USA). Laser treatment is performed in 9 sessions three days a week. Laser therapy is performed at the onset of pain. Based on previous studies, in this study, the effect of laser therapy and carbamazepine on pain in the experimental group is measured simultaneously. Intervention 2: Control group: Treatment will start with 100 mg of carbamazepine and add 100 mg to the dose once every three days (depending on the patient's pain intensity). This process continues until the pain relief (increase to the maximum allowable dose). In addition, an unreal laser is used for the control group in which the laser is on but there is no radiation. Yes - There is a plan to make this available What will be shared: all of data When: 6 months after publication To whom: people working in academic institutions Conditions: no analysis are allowed Where to obtain: registrar email How to obtain: contact with registrar Comments:
public Abbas Davodi
Hafez4 street, Ashtiani boulevard, Pardis1 alley, Ghaem-magham Street
Arak Iran (Islamic Republic of) 3817658896 +98 86 3485 0353 Abbasdavodi@yahoo.com Arak University of Medical Sciences scientific Ehsan Momeni
Arak Dentistry Faculty, Navab Street, Hepco Street
Arak Iran (Islamic Republic of) 3819693345 +98 86 3369 1355 momeni6384@gmail.com Arak University of Medical Sciences Iran (Islamic Republic of) Patients whose definitive diagnosis of trigeminal neuralgia is based on the IHS (International Headache Society) People who are seeing a doctor for the first time for treatment or have received standard medication but have had no effect on their recovery. Idiopathic disease (such as vascular malformations, brain tumors, or diseases such as multiple sclerosis that cause the disease). no limit no limit Both Pregnancy Blood problem liver functional problem Dissatisfaction to contribute in the study G50.0 Trigeminal neuralgia Treatment - Devices Treatment - Devices Intervention group: Treatment will start with 100 mg of carbamazepine and add 100 mg to the dose once every three days (depending on the patient's pain intensity). This process continues until the pain relief (increase to the maximum allowable dose). laser therapy is performed by rays with a wavelength of 940 nm with a density energy of 10 joules per square centimeter continuously (Biolase Technology, 940 diode, CA, USA). Laser treatment is performed in 9 sessions three days a week. Laser therapy is performed at the onset of pain. Based on previous studies, in this study, the effect of laser therapy and carbamazepine on pain in the experimental group is measured simultaneously. Control group: Treatment will start with 100 mg of carbamazepine and add 100 mg to the dose once every three days (depending on the patient's pain intensity). This process continues until the pain relief (increase to the maximum allowable dose). In addition, an unreal laser is used for the control group in which the laser is on but there is no radiation. Pain score. Timepoint: pain score at the beginning of the study (before the intervention) and immediately after each session of laser therapy and one month after the intervention. Method of measurement: VISUAL ANALOG SCALE. Duration of pain relief. Timepoint: At the end of study. Method of measurement: checklist. Arak University of Medical Sciences Approved 2020-09-01 Ethics committee of Arak University of Medical Sciences Arak University of Medical Sciences, Basij Square, Sardasht Place Arak Markazi Iran (Islamic Republic of)